Home

Explore NIH Technologies

Explore work by over 1,500 NIH researchers   |   Available for Licensing & Collaboration

 
 
 
 
 
 
 
 
 
 
 
 
 
Register to attend a free NCI webinar. Attendees will learn about a new a djuvanted subunit mucosal Covid-19 vaccine. Study results show that this new vaccine prevents SARS-CoV-2 transmission and infection. Most SARS-CoV-2 vaccines focus on delivering immunization through an intramuscular injection
NIH is dedicated to researching rare diseases and collaborating with partners to bring products for rare diseases to market, not only during Rare Disease Week but throughout the year. As a result of such work, on November 22, 2022, the U.S. Food and Drug Administration approved Hemgenix®, the world
Are you interested in making an impact on the improvement of global health? Are you interested in working in a dynamic organization that values its employees and offers work-life flexibility? The National Institute of Allergy and Infectious Diseases (NIAID), one of the largest Institutes at the

Explore Featured Research

Get updates on the latest and most exciting research coming out of NIH...

Read More >

Explore Featured Products

Novel and interesting products coming to market through NIH inventions and partnerships...

Read More >